| |
September 13, 2011
Regulatory approval for Elekta’s acquisition of Nucletron
|
|
Press Release
Stockholm, Sweden, September 13, 2011
The Elekta group will provide improved value for cancer patients and health care providers, by addressing a broader range of cancers, in different body sites, and across a broader range of disease stages. |
|
| |
July 22, 2011
Elekta European Users’ Conference Attracts Top Minds in Cancer Management
|
Elekta users from Europe, Asia, the Middle East, North America and Africa converged on Hotel Hohe Düne in Warnemünde, Germany June 16-19 to participate in Elekta’s fifth European Users’ Conference. Approximately 390 clinicians and scientists attended 31 presentations and workshops given by Elekta users and company representatives on a wide range of cancer management topics. The Users’ Conference was preceded by the Elekta Stereotactic Users’ Meeting, June 15-16
Read more... |
|
| |
June 21, 2011
Elekta to acquire Nucletron, complementing its product offering with world-leading brachytherapy technology
|
|
Press Release
Stockholm, Sweden, June 21, 2011
Elekta has agreed to acquire Nucletron for EUR 365 million in cash. The acquisition is expected to be accretive to Elekta’s cash earnings within twelve months. The transaction remains subject to regulatory approval and is expected to close in early autumn 2011.
Through this compelling combination Elekta will offer a complete range of radiotherapy planning and delivery technologies, enhancing its combined ability to meet the clinical needs of cancer patients and health care providers throughout the world. |
|
| |
May 26, 2011
Elekta and ScandiDos Sign Distributor Agreement for Pre-Treatment Verification Tool for ...
|
Elekta and ScandiDos AB have entered into a non-exclusive global agreement to distribute ScandiDos’s Delta4PT quality assurance (QA) tool. Delta4PT can be used with Intensity Modulated Radiation Therapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT) techniques to provide complete pre-treatment QA that ensures that the dose prescribed in treatment plans is delivered accurately and safely to patients.
Read more... |
|
| |
May 24, 2011
Elekta to Feature Certified MOSAIQ EHR at Electronic Health Records Lab During the 2011 ASCO ...
|
For the fifth straight year, Elekta has been selected to demonstrate at the American Society of Clinical Oncology (ASCO) Electronic Health Records (EHR) Lab, June 4-6, at McCormick Place in Chicago. In the spotlight will be Elekta’s MOSAIQ® Oncology Information System, the first and only oncology-specific comprehensive EMR certified for Meaningful Use under the federal government’s HITECH Act. MOSAIQ is fully prepared for centers planning attestation in 2011 or 2012.
Read more... |
|
| |
March 28, 2011
Elekta Releases MOSAIQ Oncology Information System Interface to Xstrahl Treatment Units
|
Elekta’s MOSAIQ® version 2.20 now includes an interface to Xstrahl’s superficial and orthovoltage radiotherapy systems, enabling users of these therapy machines to prepare, deliver and record treatments via MOSAIQ. The Xstrahl family of treatment systems treats superficial tumors and benign lesions (e.g., basal cell and squamous cell carcinomas, keloid scars and dermatological conditions) with low-energy radiation.
Read more... |
|
| |
January 5, 2011
Elekta’s MOSAIQ Oncology Information System Named Category Leader in “2010 ...
|
Elekta’s MOSAIQ® Oncology Information System (OIS)—the market’s leading open-system, vendor-neutral OIS—has earned the No. 1 ranking in the oncology software category from KLAS, an independent research firm. According to KLAS, a Category Leader designation identifies top-rated vendor products in the Top 20 Best in KLAS Awards report for each market segment.
Read more... |
|
| |
December 2, 2010
Elekta to Highlight Next Generation MEG System for Studying Brain Activity at American Epilepsy ...
|
At the American Epilepsy Society’s 64th Annual Meeting, December 3-7 in San Antonio, Elekta will demonstrate its latest generation magnetoencephalography (MEG) platform for investigating human brain activity, particularly in patients with epilepsy. Raising functional mapping to the next level, Elekta Neuromag® TRIUX* addresses key MEG requirements that are critical for robust functional mapping studies. Benefits of the system include higher tolerance for magnetic interferences, new user interface features and patient comfort enhancements.
Read more... |
|
| |
November 2, 2010
Cancer treatment with ultimate precision and growth drivers highlighted at ASTRO Investor Meeting
|
|
Press Release
SAN DIEGO, USA, November 1
Elekta presented solutions for ultimate precision in cancer care at an Investor Meeting in conjunction with the 52nd annual American Society for Radiation Oncology (ASTRO) Meeting, in San Diego. Elekta also discussed the market drivers in established and emerging markets, and explained its strategy for sustainable profitable growth. |
|
| |
November 2, 2010
China expands access to cancer care with three Leksell Gamma Knife systems
|
|
Press Release
San Diego, USA, November 1, 2010
In winning a tender to deliver three Leksell Gamma Knifeâ models to hospitals in China, Elekta will help more cancer patients receive the therapy they need. The agreement also helps Elekta increase its leading market position in China. |
|
| |
November 2, 2010
Elekta Introduces MOSAIQ Data Director, Image and Data Hub for Oncology
|
Elekta’s MOSAIQ® Oncology PACS has evolved to a new level with MOSAIQ Data Director, an image and data management solution for oncology professionals that enables them to direct the interchange of images and information and address the requirements of the modern oncology workflow. Fully integrated with the MOSAIQ Oncology Information System (OIS), MOSAIQ Data Director transforms the patient chart into the centralized control point to manage, view, move and archive patient images and data. Users can harness the new Web-based viewer to explore data and archived images or objects online using powerful 3D functionality.
Read more... |
|
| |
September 5, 2010
Elekta’s annual report 2009/10
|
|
Elekta’s annual report for the fiscal year 2009/10 is now available on the company’s website and is also enclosed with this press release. |
|
| |
August 23, 2010
Notice of Annual General Meeting of Elekta AB (publ)
|
|
Shareholders in Elekta AB (publ) are hereby invited to attend the Annual General Meeting to be held on Tuesday, September 21, 2010, at 3:00 p.m. at Polstjärnan Konferens, Sveavägen 77, Stockholm. |
|
| |
June 16, 2010
Repurchase of Elekta shares
|
|
The Board of Directors of Elekta AB (publ) has decided to utilize the authorization received from the Annual General Meeting to repurchase shares in the company. |
|
| |
December 29, 2009
ELEKTA WINS WORLD CLASS MANUFACTURING AWARD
|
|
Elekta, the world-leading manufacturer of treatment solutions for cancer and brain disorders, has been awarded the prestigious World Class Manufacturing award by The Manufacturer magazine. The award was given in recognition of the quality work produced each year by Elekta manufacturing staff. |
|
| |
December 29, 2009
Elekta wins World Class Manufacturing Award
|
Elekta, the world-leading manufacturer of treatment solutions for cancer and brain disorders, has been awarded the prestigious World Class Manufacturing award by The Manufacturer magazine. The World Class Manufacturing award was given in recognition of the quality work produced each year by Elekta manufacturing staff.
Read more... |
|
| |
November 24, 2009
Elekta Compact brings Radiation Therapy to patients in India
|
The Indo-American Cancer Institute and Research Center is the first in India to treat cancer patients with Elekta Compact™, Elekta’s robust, cost-effective linear accelerator for radiation therapy that addresses the cancer care needs of a wider population. The first patient treated on the system was a 52-year-old woman with breast cancer.
Read more... |
|
| |
November 2, 2009
Elekta presents new Image-Guidance Solutions at Capital Markets Day in Chicago, USA
|
At Elekta’s Capital Markets Day held in connection to the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO), in Chicago, USA, Elekta presented new tools for improved clinical precision, workflow efficiency and patient comfort. Highlights included Intuity™*and Symmetry™* advanced image-guidance solutions that build upon the company’s existing expertise.
Read more... |
|
| |
October 30, 2009
ELEKTA INVESTOR MEETING AT ASTRO ON NOVEMBER 2, 2009
|
|
REMINDER
Stockholm, October 30, 2009
Elekta invites you to an investor meeting in conjunction with the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO), in Chicago, USA. |
|
| |
September 15, 2009
REPORT FROM ELEKTA’S ANNUAL MEETING 2009
|
|
PRESS RELEASE
Stockholm, Sweden, September 15, 2009
At the Annual General Meeting of Elekta AB (publ), 60 shareholders entitled to vote participated, representing 52 percent of the votes in the company.
• Dividend to shareholders of SEK 2.00 (1.75) per share.
• Akbar Seddigh, Carl G. Palmstierna, Tommy H. Karlsson, Laurent Leksell, Hans Barella, Birgitta Stymne Göransson, Luciano Cattani and Vera Kallmeyer were reelected to the Board. |
|
| |
September 9, 2009
Hitachi selects software solutions from Elekta for Proton Therapy Center in Japan
|
Hitachi has selected Elekta to provide workflow enhancing software for its PROBEAT® proton therapy facility at West Medical Center in Nagoya, Japan. Enabling the facility to manage patient data in a chartless, paperless environment, the facility is the second Hitachi-equipped center to implement MOSAIQ®, Elekta’s oncology information system (OIS) for cancer care.
Read more... |
|
| |
September 4, 2009
ELEKTA’S ANNUAL REPORT 2008/09
|
|
PRESS RELEASE
Stockholm, Sweden, September 4, 2009
Elekta’s annual report for the fiscal year 2008/09 is now available on the company’s website and is also enclosed with this press release. |
|
| |
September 4, 2009
IBA SELECTS ELEKTA SOFTWARE FOR KEY PROTON THERAPY SITE IN PRAGUE
|
|
Elekta will provide treatment planning and information management systems for a major Proton Therapy facility in Prague, Czech Republic. The software solutions will facilitate the highest quality of patient care and lead to improved clinical efficiency. |
|
| |
September 3, 2009
Elekta Technology At Work In 94 Percent Of America's Top Cancer Hospitals
|
U.S. News & World Report recently issued its annual list of America’s best hospitals and 94 percent of the top cancer hospitals in the country are users of Elekta solutions. For patients throughout the U.S., this means the vast majority of the best cancer treatment facilities also have the best information management, treatment planning and delivery systems available.
Read more... |
|
| |
September 2, 2009
ELEKTA NAMES NEW CEO FOR NORTH AMERICAN ORGANIZATION
|
|
Press Release
Stockholm, Sweden, September 2, 2009
James Hoey has been named CEO of Elekta Holdings with overall responsibility for all of Elekta’s North American legal entities. He will also assume responsibility for Region North America, replacing Joseph Jachinowski who has decided to leave the company for an external position. |
|
| |
August 18, 2009
NOTICE OF ANNUAL GENERAL MEETING OF ELEKTA AB
|
|
Press Release
Stockholm, Sweden, August 18, 2009
Shareholders in Elekta AB (publ) are hereby invited to attend the Annual General Meeting to be held on Tuesday, September 15, 2009, at 3:00 p.m. at Polstjärnan Konferens, Sveavägen 77, Stockholm. |
|
| |
August 12, 2009
PROCURE AND INTEGRIS CHOOSE ELEKTA SOFTWARE SOLUTIONS
|
|
Press Release
Stockholm, Sweden, August 12, 2009
ProCure Treatment Centers, Inc., and INTEGRIS Health will use Elekta’s MOSAIQ® Oncology Information System and XiO® treatment planning solutions to manage and optimize its clinical and administrative workflows. |
|
| |
July 21, 2009
C-RAD SENTINEL™ SELECTED AS ELEKTA PREFERRED SOLUTION FOR INTRA FRACTION MOTION DETECTION
|
|
Press Release
Stockholm, Sweden, July 21, 2009
Elekta and C-RAD have reached an agreement where the Sentinel™ laser scanner system has been selected as the Elekta preferred solution for optical surface tracking. Elekta’s customers will be offered this superior technology for patient positioning and intra fraction motion detection without the use of markers. |
|
| |
July 14, 2009
Juntendo University begins VMAT treatments for Prostate Cancer
|
On April 13, Juntendo University (Tokyo, Japan) became the third facility in Japan to begin using Elekta Synergy® to treat prostate patients with Volumetric Modulated Arc Therapy (VMAT). Using VMAT, treatment times can be dramatically shorter and treatment margins are much more conformal than with conventional IMRT. And VMAT requires significantly fewer MUs than conventional IMRT, reducing total MU delivery by up to 50 percent.
Read more... |
|
| |
June 26, 2009
First Elekta VMAT Facility in Japan Approaches One-Year Milestone
|
University of Tokyo Hospital has been treating patients for nearly one year with Elekta Volumetric Modulated Arc Therapy (VMAT). The hospital was the first facility in Japan to use this revolutionary cancer-fighting tool, which can shorten radiation treatment times and provide state-of-the-art precision in dose control to give cancer patients the best possible outcomes.
Read more... |
|
| |
June 18, 2009
ELEKTA PROVIDES VMAT AND RADIOSURGERY SOLUTIONS FOR NEW JERSEY HEALTH SYSTEM
|
|
Press Release
Stockholm, Sweden, June 18, 2009
CentraState Medical Center (Freehold, New Jersey) has purchased two new state-of-the-art Elekta radiation therapy treatment systems, both with Volumetric Modulated Arc Therapy (VMAT). The first site in the world to have both Elekta Axesse and Elekta Infinity, CentraState will offer the most advanced cancer care available to its patients. |
|
| |
June 18, 2009
Elekta Provides VMAT and Radiosurgery Solutions for New Jersey Health System
|
CentraState Medical Center (Freehold, New Jersey) has purchased two new state-of-the-art Elekta radiation therapy treatment systems, both with Volumetric Modulated Arc Therapy (VMAT). The first site in the world to have both Elekta Axesse and Elekta Infinity, CentraState will offer the most advanced cancer care available to its patients.
Read more... |
|
| |
June 15, 2009
UPDATED: ELEKTA’S CAPITAL MARKETS DAY
|
|
Stockholm, June 15, 2009
Elekta is pleased to invite to a Capital Markets Day on June 15 in Stockholm, Sweden for a strategic update and a closer look at Elekta’s markets. |
|
| |
June 15, 2009
ELEKTA SIGNS COOPERATIVE AGREEMENT WITH SWEDISH EXPORT CREDIT CORPORATION
|
|
Stockholm, June 15, 2009
The medical technology company Elekta has entered a cooperative agreement with SEK, the Swedish Export Credit Corporation. The agreement entails customer financing and applies globally with the exception of North America, where Elekta already has an established partner for customer financing. |
|
| |
May 28, 2009
Elekta delivers 3D Brain Mapping Technology to leading German brain research center
|
The University Hospital at Heinrich-Heine-University (HHU, Düsseldorf, Germany) has installed Elekta Neuromag®, a device for non-invasive measurement of brain activity using Magnetoencephalography (MEG) technology. Completely non-invasive and painless, MEG is a powerful tool used for studying normal brain function, as well as brain disorders, such as epilepsy and autism.
Read more... |
|
| |
May 27, 2009
ELEKTA AND THE OTTAWA HOSPITAL FORGE LONG-TERM STRATEGIC PARTNERSHIP AGREEMENT
|
|
Press Release
Stockholm, Sweden, May 27, 2009
Elekta and The Ottawa Hospital (Ottawa, Ontario) have embarked on a decade-long mutual support project that will create an advanced cancer treatment centre. Part of The Ottawa Hospital, The Ottawa Hospital Cancer Centre (TOHCC), will be equipped with radiation therapy systems, as well as workflow enhancing software and treatment planning systems, enabling TOHCC to provide sophisticated therapeutic services in a chartless, paperless clinical environment. |
|
| |
May 27, 2009
Elekta and The Ottawa Hospital forge long-term strategic partnership agreement
|
Elekta and The Ottawa Hospital (Ottawa, Ontario) have embarked on a decade-long mutual support project that will create an advanced cancer treatment centre. Part of The Ottawa Hospital, The Ottawa Hospital Cancer Centre (TOHCC), will be equipped with radiation therapy systems, as well as workflow enhancing software and treatment planning systems, enabling TOHCC to provide sophisticated therapeutic services in a chartless, paperless clinical environment.
Read more... |
|
| |
May 26, 2009
PROCURE TREATMENT CENTERS TO EQUIP CHICAGO FACILITY WITH SOFTWARE SOLUTIONS FROM ELEKTA
|
|
Press Release
Stockholm, Sweden, May 26, 2009
ProCure Treatment Centers, Inc., (ProCure) has selected Elekta to provide workflow enhancing software and treatment planning systems for its second IBA-equipped proton therapy center, which is under construction in suburban Chicago. ProCure collaborates with radiation oncology practices and hospitals to build and operate proton therapy centers. |
|
| |
May 18, 2009
Elekta and Nucletron combine forces to market leading software
|
Elekta and Nucletron have reached an agreement to market and license Elekta’s software system MOSAIQ®. Nucletron’s existing Oncentra® Visir and Oncentra® Information Management customers will be offered a high-quality solution with excellent future prospects of continued innovation from the world’s largest supplier of oncology software.
Read more... |
|
| |
May 17, 2009
ELEKTA AND NUCLETRON COMBINE FORCES TO MARKET LEADING SOFTWARE
|
|
Press Release
Stockholm, Sweden, May 18, 2009
Elekta and Nucletron have reached an agreement to market and license Elekta’s software system MOSAIQ®. Nucletron’s existing Oncentra® Visir and Oncentra® Information Management customers will be offered a high-quality solution with excellent future prospects of continued innovation from the world’s largest supplier of oncology software. |
|
| |
May 11, 2009
U.K. CANCER CENTRE BEGINS INNOVATIVE RADIOTHERAPY TREATMENT WITH FOUR ELEKTA SYSTEMS
|
|
Press Release
Stockholm, Sweden, May 11, 2009
Velindre Cancer Centre (Cardiff, Wales, U.K.) has awarded Elekta with a multiple Elekta Synergy® order, bringing the department’s installation to four. All four systems will be used to facilitate Volumetric Modulated Arc Therapy (VMAT), a treatment technique that offers shorter treatment times while providing more precise control of the radiation dose to maximize safety to nearby normal tissues. This latest order will see the replacement of existing third party vendor equipment together with implementing MOSAIQ® as the sole patient information system. |
|
| |
May 11, 2009
U.K. Cancer Centre Begins Innovative Radiotherapy Treatment With Four Elekta Systems
|
Velindre Cancer Centre (Cardiff, Wales, U.K.) has awarded Elekta with a multiple Elekta Synergy® order, bringing the department’s installation to four. All four systems will be used to facilitate Volumetric Modulated Arc Therapy (VMAT), a treatment technique that offers shorter treatment times while providing more precise control of the radiation dose to maximize safety to nearby normal tissues. This latest order will see the replacement of existing third party vendor equipment together with implementing MOSAIQ® as the sole patient information system.
Read more... |
|
| |
February 26, 2009
NEW TREATMENT WITH LEKSELL GAMMA KNIFE PERFEXION INTRODUCED IN JAPAN
|
|
Press Release
Stockholm, Sweden, February 26, 2009
Leksell Gamma Knife® Perfexion™, Elekta's new system for stereotactic radiosurgery, has been used for the first time to treat patients at the Jiro Suzuki Memorial Gamma House, Furukawa Seiryo Hospital, in Miyagi, Japan. |
|
| |
February 10, 2009
ELEKTA: INVITATION TO TELEPHONE CONFERENCE
|
|
Elekta’s interim report for the third quarter 2008/09 will be published on Thursday, March 5 at around 8.30 CET. A telephone conference will be held the same day at 10.00-11.00 CET. |
|
| |
November 21, 2008
ELEKTA: INVITATION TO TELEPHONE CONFERENCE
|
|
Stockholm, Sweden, November 21, 2008
Elekta’s interim report for the second quarter 2008/09 will be published on Thursday, December 4 at around 13.00 CET and a telephone conference will be held the same day at 16.00 CET. |
|
| |
November 11, 2008
INVITATION TO TELEPHONE CONFERENCE
|
|
Stockholm, Sweden, November 11, 2008
Elekta’s interim report for the second quarter 2008/09 will be published on Thursday, December 4 at around 13.00 CET and a telephone conference will be held the same day at 16.00 CET. |
|
| |
September 19, 2008
ELEKTA ANNOUNCES AVAILABILITY OF ELEKTA INFINITY WITH VMAT TECHNOLOGY FOR FAST, MORE PRECISE TREATMENT OF CANCER
|
|
Company unveils best-in-class treatment solutions at ASTRO’s 50th Annual Meeting
Press Release
Boston, MA, USA September 19, 2008
Elekta, pioneering significant innovations and clinical solutions for cancer and neurological conditions, today announced new product offerings from the Elekta Group. Topping the list of innovations is Elekta Infinity; the company’s most advanced digital linear accelerator, now available to customers in the United States. Elekta Infinity increases speed and precision in delivering Volumetric Modulated Arc Therapy (VMAT), offering patients shortened treatment times with the highest degree of precision. |
|
| |
September 18, 2008
REPORT FROM ELEKTA’S ANNUAL MEETING 2008
|
|
PRESS RELEASE
Stockholm, Sweden, September 18, 2008
At the Annual General Meeting of Elekta AB (publ), 228 shareholders entitled to vote participated, representing 51.6 percent of the votes in the company.
• Dividend to shareholders of SEK 1.75 (1.00) per share.
• Akbar Seddigh, Carl G. Palmstierna, Tommy H. Karlsson, Laurent Leksell, Hans Barella and Birgitta Stymne Göransson were reelected to the Board.
• Luciano Cattani and Vera Kallmeyer were newly elected to the Board. |
|
| |
September 16, 2008
Elekta Announces Availability of Elekta Infinity with VMAT Technology for Fast, More Precise ...
|
ASTRO Booth #601 -- Elekta, pioneering significant innovations and clinical solutions for cancer and neurological conditions, today announced new product offerings from the Elekta Group. Topping the list of innovations is Elekta Infinity; the company’s most advanced digital linear accelerator, now available to customers in the United States. Elekta Infinity increases speed and precision in delivering Volumetric Modulated Arc Therapy (VMAT), offering patients shortened treatment times with the highest degree of precision.
Read more... |
|
| |
September 15, 2008
ELEKTA ANNOUNCES NEXT-GENERATION RADIATION TREATMENT TECHNOLOGIES AT ESTRO 27
|
|
Gothenburg, Sweden (September15, 2008) -- Elekta, a human care company pioneering significant innovations and clinical solutions for cancer and brain disorders, are currently exhibiting several important innovations in radiation therapy and radiosurgery at the 27th annual meeting of ESTRO, The European Society for Therapeutic Radiology and Oncology. |
|
| |
September 15, 2008
PRESBYTERIAN CANCER CENTER TO OFFER CANCER PATIENTS HIGH-END VMAT TREATMENTS WITH THE ...
|
Presbyterian Cancer Center – Dallas, a joint venture between Presbyterian Hospital of Dallas and Texas Oncology, PA, recently installed an Elekta Infinity system, enabling the facility to begin treating patients with Volumetric Modulated Arc Therapy (VMAT). Elekta Infinity is the facility’s first image guided linear accelerator, and will allow the Center to offer patients shortened treatment times with the highest degree of precision.
Read more... |
|
| |
September 12, 2008
Elekta Announces Availability of ERGO++ For VMAT Treatment Planning
|
Elekta, a human care company pioneering significant innovations and clinical solutions for treating cancer and neurological conditions, today announced, the clinical release of ERGO++ 1.7.1. for Volumetric Modulated Arc Therapy (VMAT), a new treatment technique offering shorter treatment times with the highest degree of precision. Building upon the experience of Arc Modulation, ERGO++ for VMAT can be used with a wide range of equipment, including mini and micro MLCs in addition to the Elekta MLCi (10mm) and Beam Modulator (4mm, full interdigitation).
Read more... |
|
| |
September 9, 2008
The Canadian Association of Radiation Oncology and Elekta Award Research Fellowship
|
Radiation oncology and medical technology groups award the second annual
CARO-Elekta Research Fellowship to Dr. Scott Carlyle Morgan
Vancouver, BC – The Canadian Association of Radiation Oncology (CARO), along with international medical-technology group Elekta, are pleased to award the 2008 CARO-Elekta Research Fellowship to Radiation Oncologist, Dr. Scott Carlyle Morgan. The $75,000 fellowship, provided by Elekta, will enable Dr. Morgan to conduct research with the Uro-Oncology Unit at the Royal Marsden Hospital in London, England with Professor David Dearnaley. His research will revolve around a newly emerging approach to treating prostate cancer that involves the delivery of very precise radiation treatment only to regions of the prostate gland that harbour cancer. He is scheduled to begin his research in November 2008.
Read more... |
|
| |
September 3, 2008
NOTICE OF ANNUAL GENERAL MEETING OF ELEKTA AB
|
|
PRESS RELEASE
Stockholm, Sweden, September 3, 2008
Shareholders in Elekta AB (publ) are hereby invited to attend the Annual General Meeting to be held on Thursday, September 18, 2008, at 3:00 p.m. at Polstjärnan Konferens, Sveavägen 77, Stockholm. |
|
| |
August 29, 2008
CMS, INC., AN ELEKTA COMPANY, ANNOUNCES FIRST CANCER PATIENTS TREATED WITH MONACO™ RADIATION TREATMENT PLANNING SYSTEM
|
|
Press Release
St Louis, Missouri, USA, August 29, 2008
CMS, Inc., an Elekta Company and worldwide leader in radiation treatment planning and workflow management solutions, announced that three sites have delivered clinical treatments utilizing Monaco™, its next-generation Intensity Modulated Radiotherapy (IMRT) treatment planning system. Allegheny General Hospital in Pittsburgh, Pennsylvania, Erasmus Medical Center in Rotterdam, Netherlands, and Froedtert Memorial Lutheran Hospital in Milwaukee, Wisconsin, have all begun producing treatment plans with the application. |
|
| |
August 29, 2008
CMS, Inc., An Elekta Company, Announces First Cancer Patients Treated with Monaco™ ...
|
CMS, Inc., an Elekta Company and worldwide leader in radiation treatment planning and workflow management solutions, today announced that three sites have delivered clinical treatments utilizing Monaco™, its next-generation Intensity Modulated Radiotherapy (IMRT) treatment planning system. Allegheny General Hospital in Pittsburgh, Pennsylvania, Erasmus Medical Center in Rotterdam, Netherlands, and Froedtert Memorial Lutheran Hospital in Milwaukee, Wisconsin, have all begun producing treatment plans with the application.
Read more... |
|
| |
August 26, 2008
INVITATION TO INVESTOR MEETING
|
|
Stockholm, Sweden, August 26, 2008
Elekta is pleased to invite analysts and investors to an investor meeting held in conjunction with the meeting of ASTRO (American Society for Therapeutic Radiology and Oncology) in Boston, USA. |
|
| |
August 22, 2008
INVITATION TO TELEPHONE CONFERENCE
|
|
Elekta will publish its three months interim report 2008/09 on Thursday September 18 at around 13.00 CET and a telephone conference will be held the following day, Friday September 19, at 10.00 CET. |
|
| |
July 30, 2008
SEATTLE’S SWEDISH CANCER INSTITUTE FIRST IN U.S. TO TREAT CANCER PATIENT WITH ELEKTA VMAT
|
|
Press Release
Seattle, WA and Atlanta, GA – July 30, 2008
A patient with pancreatic cancer recently became the first person in the United States to receive treatment using Elekta VMAT (Volumetric intensity Modulated Arc Therapy) at Seattle’s Swedish Cancer Institute. This revolutionary new technology dramatically decreases treatment times – delivering a higher dose to the tumor target without compromising coverage and patient safety. |
|
| |
July 25, 2008
Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting
|
The Elekta Family of Companies will showcase their unique line of cancer treatment solutions at the 2008 American Association of Physicists in Medicine (AAPM) annual meeting, demonstrating how the joint forces of Elekta, IMPAC and CMS are delivering cutting-edge radiation therapy planning and delivery solutions that streamline the treatment process to create a better experience for patients, as well as enhance clinician efficiency.
Read more... |
|
| |
July 17, 2008
ELEKTA INVESTOR MEETING, 22 SEPTEMBER 2008
|
|
Stockholm, Sweden, July 17, 2008
In conjunction with ASTRO, the American Society for Therapeutic Radiology and Oncology, 50th annual meeting to be held in Boston on September 21-25, Elekta will arrange an investor meeting on Monday, September 22 to start at 2 p.m. EDT. |
|
| |
June 15, 2008
ELEKTA VMAT 510(k) CLEARANCE WELCOMED BY US RADIATION ONCOLOGISTS
|
|
Press Release
Stockholm, Sweden, June 16, 2008
Elekta has received FDA 510(k) clearances for its groundbreaking Elekta VMAT solution, allowing US cancer specialists to both plan and deliver radiation using a technique which has the potential to revolutionize the practice of radiation oncology. This news has been eagerly anticipated by US cancer clinics as it offers both significant benefits to their patients and the opportunity to increase patient volumes. |
|
| |
June 15, 2008
Year-end report May – April 2007/08
|
|
• Order bookings rose 15 percent to SEK 5,882 M (5,102). Based on unchanged exchange rates order bookings rose 21 percent. Order bookings for the fourth quarter rose 40 percent to SEK 2,181 M (1,563), which is a record for a single quarter. Order backlog April 30, 2008 was also at a record level of SEK 5,069 (4,247) M.
• Net sales rose 12 percent to SEK 5,081 M (4,525). Based on unchanged exchange rates net sales rose 18 percent.
• Operating profit rose 28 percent to SEK 650 M (509) and operating margin was 13 percent (11).
• Profit after taxes was SEK 406 M (346). Profit per share after dilution was SEK 4.44 (3.70).
• Cash flow from operating activities improved by SEK 169 M to positive SEK 319 M (pos. 150). Cash flow after investments was negative SEK 280 M (neg. 107). Acquisitions were included with SEK 553 M (144).
• In fiscal year 2008/09, net sales are expected to grow by over 15 percent in local currency. Operating profit is expected to grow by more than 15 percent.
• The Board proposes a 75 percent increase of dividend of SEK 1.75 (1.00) per share, corresponding to around SEK 160 M and 39 percent of net profit. |
|
| |
May 26, 2008
LEKSELL GAMMA KNIFE® PERFEXION™ RECEIVES REGULATORY APPROVAL IN JAPAN
|
|
Press Release
Stockholm, Sweden, May 26, 2008
The Japanese Ministry for Health, Labor and Welfare, MHLW, has given approval for Leksell Gamma Knife® Perfexion™, the world-leading clinical solution for non-invasive radiosurgical treatments of tumors, vascular malformations and other brain disorders. Elekta, the international medical technology group and developer of Gamma Knife® surgery, will now be able to deliver and install this advanced technology at new and existing customer sites in Japan. |
|
| |
May 21, 2008
ELEKTA SEES RECORD ATTENDANCE AND RECORD NUMBER OF SUBMITTED ABSTRACTS AT INTERNATIONAL LEKSELL GAMMA KNIFE® SOCIETY MEETING IN QUEBEC, CANADA
|
|
PRESS RELEASE
Stockholm, Sweden, May 21, 2008
At the 14th International Leksell Gamma Knife® Society Meeting on May 18-22, over 500 participants including neurosurgeons, radiation oncologists and other medical specialists using Leksell Gamma Knife for treatment of tumors and other brain disorders convened at the historic Château Frontenac Hotel in Quebec, Canada. During the meeting, 260 oral and poster presentations covered treatment of malignant and benign brain tumors, functional neurosurgery, imaging & biology as well as physics & technology. On Wednesday, May 21, the prestigious Pioneers in Radiosurgery Award was presented to John Flickinger, M.D., Professor of Radiation Oncology and Neurological Surgery at the University of Pittsburgh for his early pioneering work on prediction of complications following Gamma Knife® surgery. |
|
| |
May 19, 2008
AUSTRALIAN SAFETY AGENCY ORDERS ELEKTA SYNERGY® AS GOLD STANDARD FOR CALIBRATION AND DOSIMETRY
|
|
Press Release
Stockholm, Sweden, May 19, 2008
Elekta, world-leading provider of radiation therapy and radiosurgery solutions, is pleased to announce that the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) has joined other world-class physics standards centers with its order of an Elekta linear accelerator. ARPANSA will accept delivery of an Elekta Synergy® system this summer, and will utilize the Elekta system’s high level of stability for its national physics measurements. |
|
| |
May 2, 2008
ELEKTA RECEIVES AN ORDER TO DELIVER COMPREHENSIVE SUITE OF ADVANCED CANCER TREATMENT TECHNOLOGIES TO NEW CENTER IN SYDNEY INCLUDING THE FIRST LEKSELL GAMMA KNIFE® TO BE INSTALLED IN AUSTRALIA
|
|
Press Release
Stockholm, Sweden, May 2, 2008
In a collaborative effort, Macquarie University, incorporating The Australian School of Advanced Medicine, together with Dalcross Private Hospital has launched an ambitious project to improve access to advanced radiosurgery and radiation therapy for patients in Sydney and across Australia’s New South Wales region. The medical technology group Elekta, based in Stockholm, Sweden, has been selected as the main provider of a comprehensive suite of cancer and neurosurgical treatment solutions and supporting IT systems to the new Macquarie University Private Hospital, currently under construction. |
|
| |
April 25, 2008
ELEKTA ANNOUNCES FIRST LINEAR ACCELERATOR ORDER IN NEW ZEALAND
|
|
Press Release
Stockholm, Sweden, April 25, 2008
Elekta, a world leader in clinical solutions for radiosurgery and radiation therapy, has finalized its first-ever New Zealand order. Auckland Radiation Oncology Limited (ARO) have decided to invest in a new Elekta Synergy® system with MOSAIQ™ EMR and Elekta VMAT, for delivery in April. |
|
| |
March 10, 2008
Nine-month interim report May – January 2007/08
|
|
• Order bookings rose 5 percent to SEK 3,701 M (3,539). Based on unchanged exchange rates order bookings rose 10 percent. Order backlog January 31, 2008 was at an all time high level of SEK 4,581 M.
• Net sales rose 7 percent to SEK 3,285 M (3,082). Based on unchanged exchange rates net sales rose 11 percent.
• Operating profit rose 9 percent to SEK 267 M (246) and operating margin was 8 percent (8).
• Profit after taxes was SEK 174 M (183). Profit per share after dilution was SEK 1.91 (1.95).
• Cash flow from operating activities improved by SEK 187 M to positive SEK 89 M (neg. 98). Cash flow after investments was negative SEK 35 M (neg. 324). Acquisitions were included with SEK 95 M (144).
• Recognizing the challenge in delivering high volumes in the fourth quarter, Elekta reiterates the full year outlook of net sales growth in local currency over 12 percent and operating profit growth of 25-30 percent.
• In March, Elekta concluded the acquisition of CMS, a leader in the development, sales and support of advanced radiation therapy planning solutions, for a total cash consideration representing an enterprise value of USD 75 M. |
|
| |
March 4, 2008
ELEKTA COMPLETES THE ACQUISITION OF CMS
|
|
Press Release
Stockholm, Sweden, March 4, 2008
The international medical technology group Elekta AB (publ) (STO: EKTAb) today announced the completion of its announced acquisition of CMS, Inc. for total cash consideration representing an enterprise value of USD 75 M. |
|
| |
February 22, 2008
ELEKTA: 9 MONTHS REPORT AND INVITATION TO TELECONFERENCE
|
|
INVITATION
Stockholm, February 22, 2008
Elekta will release its 9 months report for fiscal year 2007/08 as follows:
• Report: Monday, March 10, 2008, around 13.00 (1 pm) CET
• Teleconference, March 10, 2008, at 15.00 (3 pm) CET
• REMINDER: Investor Day in Crawley, UK, March 12 (details below) |
|
| |
February 18, 2008
ELEKTA SIGNS AGREEMENT TO ACQUIRE CMS
|
|
Press Release
Stockholm, Sweden, February 18, 2008
Elekta AB (publ) (STO:EKTAb) a world leader in clinical solutions for radiation therapy and radiosurgery, today announced that it has signed a purchase agreement to acquire CMS Inc. for a total cash consideration representing an enterprise value of USD 75 M. Closing of the transaction is expected in March. |
|
| |
January 28, 2008
INVITATION TO INVESTOR DAY IN CRAWLEY, UK, MARCH 12
|
|
Invitation
Stockholm, Sweden, January 28, 2008
Elekta will publish its 9 month report on March 10 at around 13.00 CET followed by a teleconference at 15.00 CET on the same day.
On March 12, Elekta will arrange an Investor Day at the company’s Product Supply Center Oncology in Crawley, UK, (close to Gatwick Airport). |
|
| |
January 24, 2008
PROCURE SELECTS IMPAC AS PROVIDER OF ONCOLOGY INFORMATION SYSTEMS
|
|
PRESS RELEASE
Stockholm, Sweden, January 24, 2008
ProCure Treatment Centers, Inc (ProCure) has announced that it has selected IMPAC Medical Systems (IMPAC), an Elekta Company, as a preferred provider of oncology information systems (OIS) for its IBA-equipped proton beam therapy centers. ProCure designs, builds and operates proton beam therapy centers in partnership with local radiation oncologists and community hospitals. |
|
| |
January 23, 2008
ELEKTA’S BOARD DECIDES TO REPURCHASE OWN SHARES AND ADJUST NET DEBT/EQUITY OBJECTIVE
|
|
PRESS RELEASE
Stockholm, Sweden, January 23, 2008
The Board of Directors of Elekta AB (publ) has decided to utilize the authorization the Board received from the Annual General Meeting to repurchase shares in the company. In conjunction, the Board of Directors has also decided to adjust the company’s financial objective for net debt/equity from below 0.25 to below 0.50. |
|
| |
January 21, 2008
ELEKTA TO SUPPLY CHU DE POITIERS HOSPITAL CENTER IN FRANCE WITH ADVANCED TECHNOLOGY FOR IMAGE GUIDED RADIATION THERAPY
|
|
PRESS RELEASE
Stockholm, Sweden, January 21, 2008
CHU (University Hospital Center) de Poitiers has selected Elekta as the main partner in an ambitious program to improve radiation therapy treatment capacity in the Poitou-Charente region. Replacing equipment from a different vendor, the hospital recently assigned Elekta to deliver three Elekta Synergy® digital linear accelerator systems for intensity modulated and image guided radiation therapy. The order is valued at close to EUR 5 M. |
|
| |
January 18, 2008
ELEKTA ANNOUNCES FIRST TWO CLINICAL SITES USING VMAT CANCER TREATMENT CAPABILITY
|
|
PRESS RELEASE
Stockholm, Sweden, January 18, 2008
Elekta, a world leader in clinical solutions for radiation therapy and radiosurgery, announced today that two sites are utilizing Elekta technology to implement clinical treatments with Volumetric Modulated Arc Therapy (VMAT)*. With the recent CE designation of VMAT in Europe, the way has been cleared for The Royal Marsden Hospital in Sutton, UK and General Hospital Vienna in Austria to treat cancer using Elekta’s VMAT solution. |
|
| |
January 8, 2008
ELEKTA NEGOTIATES TO ACQUIRE CMS
|
|
Acquisition of leading treatment planning software developer would strengthen Elekta’s offering and accelerate the company’s expansion into high growth oncology informatics
PRESS RELEASE
Stockholm, Sweden, January 8, 2008
Elekta AB (publ) (STO:EKTAb) a world leader in clinical solutions for radiation therapy and radiosurgery, today announced that it is in exclusive negotiations based on a Letter of Intent to acquire CMS Inc. for a total cash consideration representing an enterprise value of USD 75 M. CMS is a worldwide leader in the development, sales and support of advanced radiation therapy planning solutions, supporting over 1,500 sites in clinical operation throughout the world. The transaction is subject to successful conclusion of final transaction documentation, satisfactory completion of due diligence, receipt of relevant regulatory approvals and other conditions. The negotiations are expected to be finalized by mid February 2008 and closing is estimated to take place by mid March 2008. |
|
| |
December 12, 2007
Elekta AB - Six-month interim report May – October 2007/08
|
|
• Order bookings rose 7 percent to SEK 2,472 M (2,302). Based on unchanged exchange rates or-der bookings rose 12 percent. Order backlog on October 31, 2007 was at an all time high level of SEK 4,425 M.
• Net sales rose 9 percent to SEK 2,188 M (2,014). Based on unchanged exchange rates net sales rose 14 percent.
• Operating result rose by 23 percent to SEK 195 M (159) and operating margin was 9 percent (8).
• Profit after taxes was SEK 126 M (104). Profit per share after dilution was SEK 1.38 (1.11).
• Cash flow from operating activities improved by SEK 291 M to positive SEK 140 M (neg. 151). Cash flow after investments amounted to positive SEK 22 M (neg. 343). Acquisitions were in-cluded with SEK 95 M (144).
• For the full fiscal year 2007/08, Elekta expects a net sales growth exceeding 12 percent in local currency. The earlier outlook was exceeding 10 percent. Primarily as a consequence of changes in exchange rates, Elekta now expects an operating result growth of 25-30 percent. The earlier outlook was exceeding 30 percent. |
|
| |
November 30, 2007
ELEKTA'S FOUNDER AND EXECUTIVE DIRECTOR LAURENT LEKSELL AWARDED ENTREPRENEUR OF THE YEAR – WILL REPRESENT SWEDEN IN THE WORLD FINAL
|
|
PRESS RELEASE
Stockholm, Sweden, November 30, 2007
At a gala final in Stockholm on November 29, Laurent Leksell, Elekta AB, was awarded Entrepreneur of the Year 2007 in Sweden. Crister Stark, Väderstad-Verken AB, won the category prize ”Best international growth” and Nicolas Hassbjer, HMS Industrial Networks AB, was awarded the judging panel’s special prize ”Rising star of the year”. |
|
| |
November 28, 2007
ELEKTA: 6 MONTHS REPORT AND INVITATION TO TELECONFERENCE
|
|
INVITATION
Stockholm, November 28, 2007
Elekta will release its 6 months report for fiscal year 2007/08 as follows:
• Report: Wednesday, December 12, 2007, around 13.00 (1 pm) CET
• Teleconference, December 12, 2007, at 15.00 (3 pm) CET |
|
| |
October 30, 2007
BEAUMONT HOSPITAL, ROYAL OAK TREATS ITS FIRST PATIENTS WITH ELEKTA AXESSE™
|
|
PRESS RELEASE
Los Angeles, CA, October 30, 2007
Beaumont Hospital, Royal Oak (Royal Oak, Michigan, USA) has performed its first treatments using the new Elekta Axesse™, the ultimate whole-body cancer treatment system. Elekta Axesse sets new standards for precision and therapeutic efficacy in stereotactic radiation therapy, which involves three-dimensional CT imaging for tumor targeting accuracy. The new robotic, image-guided stereotactic radiation system treats cancer patients quickly and effectively with highly accurate tumor targeting |
|
| |
October 29, 2007
ELEKTA ANNOUNCES ELEKTA INFINITY – A NEW SYSTEM FOR FASTER AND MORE PRECISE TREATMENT OF CANCER TUMORS
|
|
PRESS RELEASE
Stockholm, Sweden, October 29, 2007
Elekta, a global leader in radiation oncology and non-invasive neurosurgery solutions, announced Elekta Infinity*, the definitive new digital linear accelerator optimized for delivering Volumetric Intensity Modulated Arc Therapy* (VMAT), a very fast Intensity Modulated Radiation Therapy (IMRT) treatment delivered in single or multiple arcs, at the 49th Annual Meeting of The American Society for Therapeutic Radiology and Oncology (ASTRO). The meeting is being held October 28-November 1, at the Los Angeles Convention Center. |
|
| |
October 27, 2007
IBA AND ELEKTA INITIATE GLOBAL PARTICLE THERAPY PROGRAM AT ASTRO
|
|
PRESS RELEASE
Los Angeles, CA, October 27, 2007
IBA (Ion Beam Applications S.A.: Reuters IBAB.BR and Bloomberg IBAB.BB) and Elekta AB (publ) (Stockholm, Sweden: EKTA.ST), edtoday announced a global particle therapy collaboration program to optimize the seamless integration of proton therapy delivery and information management systems within the radiation oncology environment. Both companies currently showcase their products at the 49th Annual Meeting of ASTRO (American Society for Therapeutic Radiology and Oncology) held in Los Angeles, CA, USA, from October 28 to November 1, 2007. |
|
| |
October 12, 2007
FINDING HOPE FOR AUTISM – NEW BRAIN RESEARCH TECHNOLOGY CENTRE OPENED BY HRH PRINCESS ANNE
|
|
PRESS RELEASE
Stockholm, Sweden, October 12, 2007
The Oxford Neurodevelopmental Magnetoencephalography (MEG) Centre, featuring advanced new Elekta Neuromag® technology for the investigation of autism, has been officially opened today at the University Department of Psychiatry, Warneford Hospital, in Oxford, United Kingdom by HRH Princess Anne, The Princess Royal. |
|
| |
September 26, 2007
ELEKTA SELECTED TO SUPPLY ADVANCED RADIATION THERAPY CAPABILITY TO GREECE’S LARGEST PRIVATE HOSPITAL
|
|
PRESS RELEASE
Stockholm, Sweden, September 26, 2007
Elekta, a world leader in advanced radiation therapy and radiosurgery has been awarded a Contract by the Diagnostic and Therapeutic Center of Athens – HYGEIA S.A. – to supply and install three linear accelerator systems, including one Elekta Axesse™ stereotactic image guided treatment system, a comprehensive network and information management system and a long-term service contract. The Contract is valued at over EUR 8 M. |
|
| |
September 25, 2007
ELEKTA ANNUAL GENERAL MEETING 2007
|
|
PRESS RELEASE
Stockholm, Sweden, September 25, 2007
The Annual General Meeting of Elekta AB (publ) 2007 was held today, September 25, at Polstjärnan Konferens in Stockholm. At the Meeting, 253 shareholders entitled to vote participated, representing 57.5 percent of the votes in the company. |
|
| |
September 24, 2007
TWO NEW ITALIAN CANCER CENTERS SELECT ADVANCED RADIATION TREATMENT TECHNOLOGY FROM ELEKTA
|
|
PRESS RELEASE
Stockholm, Sweden, September 25, 2007
Elekta has been selected by two progressive Italian hospitals opening up new radiation therapy clinics, to supply advanced and clinically proven cancer treatment systems for intensity modulated and image guided radiation therapy (IMRT & IGRT). The two clinics will play an important role in their respective region to provide first class radiation therapy and to increase cancer treatment capacity. |
|
| |
September 24, 2007
Elekta AB - Three month interim report May – July 2007/08
|
|
• Order bookings rose 15 percent to SEK 1,136 M (987). Based on unchanged exchange rates order bookings rose 20 percent. Order backlog on July 31, 2007 was at an all time high level of SEK 4,419 M.
• Net sales declined 2 percent to SEK 975 M (996). Based on unchanged exchange rates net sales rose 2 percent.
• Operating profit amounted to SEK 36 M (85) and operating margin was 4 percent (9).
• Profit after taxes amounted to SEK 20 M (60). Earnings per share after dilution was SEK 0.22 (0.63).
• Cash flow from operating activities improved by SEK 84 M to negative SEK 28 M (neg. 112). Cash flow after investments was negative SEK 145 M (neg. 142). Acquisition was included with SEK 95 M (-).
• As a result of high delivery volumes in the second quarter, operating profit for the first half of the year is expected to be significantly higher compared with the corresponding period last year. For full year 2007/08, Elekta reiterates the outlook of a net sales growth of over 10 percent in local currency and an operating profit growth of over 30 percent.
President & CEO Tomas Puusepp comments: |
|
| |
September 13, 2007
ELEKTA: Q1 REPORT AND INVITATION TO TELECONFERENCE
|
|
INVITATION
Stockholm, September 13, 2007
Elekta will release its 3 months report for fiscal year 2007/08 as follows:
• Report: Tuesday, September 25, 2007, around 13.00 (1 pm) CET
• Teleconference, September 26, 2007 at 15.00 (3 pm) CET |
|
| |
September 11, 2007
ELEKTA ANNUAL REPORT 2006/07 PUBLISHED
|
|
PRESS RELEASE
Stockholm, Sweden, September 11, 2007
Elekta has published its Annual Report for fiscal year 2006/07. The report is available on www.elekta.com together with other documentation for the Annual General Meeting on September 25. |
|
| |
September 10, 2007
ELEKTA LAUNCHES NEW LINEAR ACCELERATOR AT 2007 ESTRO TO EXPAND CANCER TREATMENT AVAILABILITY
|
|
PRESS RELEASE
Stockholm, Sweden, September 10, 2007
Elekta today unveiled a new member of the Elekta family of linear accelerators at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2007 meeting. At an unveiling ceremony in the Elekta booth, Elekta President & CEO Tomas Puusepp announced the launch of Elekta Compact™, a new addition to Elekta’s product line of linear accelerators that offers an easy to implement, more affordable solution for radiation therapy. |
|
| |
August 21, 2007
NOTICE TO ATTEND ANNUAL GENERAL MEETING IN ELEKTA
|
|
PRESS RELEASE
Stockholm, Sweden, August 21, 2007
Shareholders in Elekta AB (publ) are hereby invited to attend the Annual General Meeting to be held on Tuesday, September 25, 2007, at 3:00 p.m. at Polstjärnan Konferens, Sveavägen 77, Stockholm. |
|
|
